Anushareddy Muddasani, MD
Internal Medicine · Little Rock, ARNPI 1760919872
Payments from drug & device makers
Across 42 payments — averaging $17.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$129
- Biohaven Pharmaceuticals, Inc.$124
- Pfizer$74
- Novartis$55
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$45
- Boston Scientific$42
- plus $266 from 13 others
What the payments were for
- Food & beverage$735100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 9 | $129 |
| Biohaven Pharmaceuticals, Inc. | 1 | $124 |
| Pfizer | 5 | $74 |
| Novartis | 4 | $55 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $45 |
| Boston Scientific | 2 | $42 |
| AstraZeneca | 3 | $36 |
| AbbVie | 2 | $29 |
| Johnson & Johnson | 2 | $28 |
| Novo Nordisk | 2 | $25 |
| Amarin Pharma, Inc. | 2 | $25 |
| GSK | 1 | $20 |
| Nestle Healthcare Nutrition Inc. | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| Bayer | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Medtronic | 1 | $14 |
| Lilly USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$124
How this compares
$735 in reported general payments places this provider in the 70th percentile of 614 internal medicine providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levofloxacin | 13 | $290 |
| Atorvastatin Calcium | 19 | $214 |
| Acyclovir | 21 | $188 |
| Ondansetron OdtOndansetron | 12 | $158 |
| Levothyroxine Sodium | 15 | $116 |
| Metformin Hcl | 11 | $91 |
| Gabapentin | 12 | $54 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Little Rock
- Priyantha WijewardaneLittle Rock$43.6M
- Joseph RoseLittle Rock$1.1M
- Alexander KaczenskiLittle Rock$305K
- Manisha SinghLittle Rock$71K
- Srikanth VallurupalliLittle Rock$34K
- Aaron StrobelLittle Rock$32K
- Jeremy DavisLittle Rock$17K
- Ritesh RampureLittle Rock$13K
- Milton RoachLittle Rock$12K
- Michael CloudLittle Rock$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.